This year’s Risk Evaluation & Mitigation Strategies (REMS) Summit will be part of Fierce’s Drug Safety Week, offering attendees two additional days of drug safety and pharmacovigilance-focused case studies and panel discussions on the assessment of benefit, harm, effectiveness, and risk of pharmaceuticals to patients and how these can be effectively monitored and mitigated.
Evidera is proud to be a sponsor of the 2021 REMS Summit, and will be presenting a panel on Wednesday, January 20, from 11:15-11:55am EST titled, “Evaluate if your Organizations REMS Program Should be Outsourced or Developed Internally.” Presenters include: Cheslow D, Ancell J, Gopu K, Elhoregy K